Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Document type

Article

Version

Published version

Publication date

Publication license

cc-by (c) Ariza Cardenal, Javier et al., 2007
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/43769

Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Brucellosis is probably the commonest anthropozoonotic infection worldwide [1-3], but remains in various aspects an enigma in the 21st century [4]. Brucella melitensis remains the major cause of human disease worldwide, followed by B. abortus and B. suis, while rare but persisting cases of B. canis human infection and disease by novel Brucella pathogens of marine mammals have also emerged. The disease is re-emerging as a significant cause of travel-related disease [5] and represents an index of poor socioeconomic status (Figure 1). Its treatment is largely based even today on the principles applied half a century ago by pioneer researchers [6] and few modifications have been made in the following years, despite the emergence of new antibiotic classes and different therapeutic approaches [7].

Citation

Citation

ARIZA CARDENAL, Javier, et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Medicine. 2007. Vol. 4, num. 12, pags. 1872-1878. ISSN 1549-1277. [consulted: 15 of August of 2026]. Available at: https://hdl.handle.net/2445/43769

Export metadata

JSON - METS

Share record